Silencing Bmi1 expression suppresses cancer stemness and enhances chemosensitivity in endometrial cancer cells

Abstract

Bmi1 silencing suppresses cancer stemness in HEC1A and Ishikawa cells. Concurrent treatment with Bmi1 siRNA and cisplatin resulted in additive anticancer effect with a cell line-specific pattern, which was higher than that shown by cisplatin treatment alone.